Literature DB >> 3088632

Some behavioural and EEG effects of ascorbic acid in rats.

C Wambebe, E Sokomba.   

Abstract

Ascorbic acid (50-200 mg/kg IP) activated gross behaviour and EEG of rats. The behavioural excitation induced by d-amphetamine (2.5 mg/kg SC) was significantly potentiated by ascorbic acid (100-200 mg/kg IP). Catalepsy induced by haloperidol (0.25 mg/kg IP) was attenuated by ascorbic acid (50-200 mg/kg IP) while pentobarbitone (20 mg/kg IP)-induced sleep in rats was dose-dependently antagonised by ascorbic acid (50-400 mg/kg IP). Ascorbic acid (50-400 mg/kg IP) desynchronized the EEG of the frontal cortex and optic cortex while the EMG activity was slightly enhanced in the rat. Ascorbic acid (100 mg/kg IP) potentiated d-amphetamine (2.5 mg/kg SC)-induced EEG desynchronization and EMG activation in the rat. These results indicate that ascorbic acid exerts stimulatory effects in rats. The results also suggest that dopaminergic mechanism may contribute indirectly or directly to the observed behavioural and EEG effects of ascorbic acid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088632     DOI: 10.1007/bf00310622

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Effect of ascorbic acid on release of acetylcholine from synaptic vesicles prepared from different species of animals and release of noradrenaline from synaptic vesicles of rat brain.

Authors:  C H Kuo; F Hata; H Yoshida; A Yamatodani; H Wada
Journal:  Life Sci       Date:  1979-03-05       Impact factor: 5.037

2.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Authors:  P A JANSSEN; C J NIEMEGEERS; K H SCHELLEKENS
Journal:  Arzneimittelforschung       Date:  1965-02

3.  Antagonism of D-amphetamine by alpha-methyl-L-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response.

Authors:  J M Stolk; R H Rech
Journal:  Neuropharmacology       Date:  1970-05       Impact factor: 5.250

4.  Pharmacological properties of dehydroascorbic acid and ascorbic acid. Effects on the central and peripheral nervous systems in experimental animals.

Authors:  S E Sjöstrand
Journal:  Acta Physiol Scand Suppl       Date:  1970

5.  Correlation between multitest and single test catalepsy assessment.

Authors:  B Costall; S C Hui; R J Naylor
Journal:  Neuropharmacology       Date:  1978-09       Impact factor: 5.250

6.  Effect of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholamines.

Authors:  L C Tolbert; T N Thomas; L D Middaugh; J W Zemp
Journal:  Life Sci       Date:  1979-12-24       Impact factor: 5.037

7.  Ascorbic acid and chronic schizophrenia.

Authors:  B Pitt; N Pollitt
Journal:  Br J Psychiatry       Date:  1971-02       Impact factor: 9.319

8.  The influence of large doses of vitamin C on psychological functioning.

Authors:  D Benton
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.

Authors:  S H Snyder; D Greenberg; H I Yamumura
Journal:  J Psychiatr Res       Date:  1974       Impact factor: 4.791

10.  Influence of FLA-63 on pentobarbitone sleep in chicks and rats.

Authors:  C Wambebe; G Osuide
Journal:  Clin Exp Pharmacol Physiol       Date:  1983 Sep-Oct       Impact factor: 2.557

View more
  5 in total

Review 1.  Ascorbic Acid to Manage Psychiatric Disorders.

Authors:  Morgana Moretti; Daiane Bittencourt Fraga; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

2.  Behavioral activation in rats requires endogenous ascorbate release in striatum.

Authors:  G V Rebec; Z Wang
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 3.  Vitamin neurotoxicity.

Authors:  S R Snodgrass
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

4.  Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism.

Authors:  L K White; M Carpenter; M Block; A Basse-Tomusk; T W Gardiner; G V Rebec
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.

Authors:  Mostafa Amr; Ahmed El-Mogy; Tarek Shams; Karen Vieira; Shaheen E Lakhan
Journal:  Nutr J       Date:  2013-03-09       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.